Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TSR-033 |
| Trade Name | |
| Synonyms | TSR033|TSR 033 |
| Drug Descriptions |
TSR-033 is a humanized monoclonal antibody that targets LAG3 and inhibits binding of class II MHC molecules, potentially resulting in enhanced anti-tumor immune response, particularly in combination with other agents (PMID: 30587557). |
| DrugClasses | LAG3 Antibody 19 |
| CAS Registry Number | NA |
| NCIT ID | C142978 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cobolimab + Dostarlimab-gxly + TSR-033 | Cobolimab Dostarlimab-gxly TSR-033 | 0 | 1 |
| Dostarlimab-gxly + TSR-033 | Dostarlimab-gxly TSR-033 | 0 | 0 |
| TSR-033 | TSR-033 | 0 | 1 |
| TSR-033 + unspecified PD-1 antibody | TSR-033 unspecified PD-1 antibody | 0 | 1 |